The CRUK Urological Malignancies Programme is a synergistic conglomerate of scientists and clinicians working on multimodal laboratory, clinical and translational research strategies towards the common goal of improving outcomes for patients with urological cancers. Our programme members engage leading-edge techniques and approaches to elucidate the underlying genetics and biological mechanisms of urological malignancies, develop and assess optimal pathways for their clinical diagnosis and management, and improve the therapy pathways of patients using novel biopsy, imaging and treatment methods. Find out more...